Search Orphan Drug Designations and Approvals
-
Generic Name: | His-D-Trp-Ala-Trp-D-Phe-Lys NH2 |
---|---|
Date Designated: | 05/23/1990 |
Orphan Designation: | For the long term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
SmithKline Beecham Pharmaceuticals One Franklin Plaza Philadelphia, Pennsylvania 19101 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-